Learn how CBDA Fortified Full Spectrum can be integrated into canine osteoarthritis treatment plans.
Greencross is pleased to offer a free live webinar on 18 August 2026 exploring the latest developments in canine osteoarthritis management and the clinical application of CBDA Fortified Full Spectrum.
Presented by Dr Anita Bean, this evidence-based session has been designed for veterinarians and veterinary nurses seeking practical guidance on integrating emerging therapeutic options into osteoarthritis treatment plans. With the recent Veterinary Pain Advisory Committee (VPAC) recommendation supporting CBD as an adjunct to Beransa, the webinar will provide valuable insights into how these therapies can be used together to enhance patient outcomes.
During the session, Dr Anita Bean will discuss how CBDA Fortified Full Spectrum supports canine osteoarthritis patients through a multi-mechanistic approach targeting both inflammatory and neuropathic pain pathways. Attendees will also gain a deeper understanding of the unique pharmacological properties of CBDA, including its role as a selective COX-2 inhibitor and the potential advantages it may offer compared to CBD isolate formulations.
The webinar will cover practical prescribing considerations, including the safe use of CBDA Fortified Full Spectrum alongside NSAIDs and monoclonal antibody therapies. Dr Bean will also share dosing strategies from treatment initiation through long-term maintenance, guidance for setting realistic treatment expectations with pet parents, and specialised liposomal protocols for severe osteoarthritis cases requiring more intensive support.
Whether you are looking to stay up to date with evolving pain-management recommendations or further enhance your approach to osteoarthritis care, this webinar will deliver practical, clinically relevant insights that can be immediately applied in practice.
Event Details
Presented by: Dr Anita Bean
Date: 18 August 2026
Format: Live Online Webinar
Cost: Free
Registration is available via the Greencross Event Hub. Registered attendees will receive a Microsoft Teams link approximately one week before the webinar.
Don’t miss this opportunity to learn from Dr Anita Bean and explore the role of CBDA Fortified Full Spectrum in modern canine osteoarthritis management.
About the Speaker Dr Anita Bean
Anita is a pioneering veterinary cannabinoid educator with over 8 years of clinical experience prescribing cannabinoids as an adjuvant therapy. A University of Queensland graduate, she is a member of the Australian Veterinary Association and the Australian Veterinary Small Animal Association.
As a leading authority in veterinary cannabinoid medicine, Anita provides expert guidance and mentorship to over 500 veterinarians across Australia, ensuring CBD is prescribed with the highest standards of diligence and care. She collaborates directly with internationally renowned veterinary cannabinoid researcher Dr. Rodrigo Zamith Cunha, whose groundbreaking work includes 10 published peer-reviewed papers on CBD in veterinary medicine. Together, they co-present advanced CBD lectures as part of the College of Integrative Therapies curriculum.
A respected member of the Veterinary Cannabis Society, Anita was personally selected by the board to represent the Asia-Pacific region in an exclusive global interview, sharing her pioneering experience prescribing cannabinoids in Australia. This landmark appointment made her the first Australian veterinarian to be featured on the international stage of Veterinary Cannabis Professionals, cementing her position as a thought leader in this emerging field.